Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Sirtuins are evolutionarily conserved viral restriction factors.

Koyuncu E, Budayeva HG, Miteva YV, Ricci DP, Silhavy TJ, Shenk T, Cristea IM.

MBio. 2014 Dec 16;5(6). pii: e02249-14. doi: 10.1128/mBio.02249-14.

2.

Sirtuin Lipoamidase Activity Is Conserved in Bacteria as a Regulator of Metabolic Enzyme Complexes.

Rowland EA, Greco TM, Snowden CK, McCabe AL, Silhavy TJ, Cristea IM.

MBio. 2017 Sep 12;8(5). pii: e01096-17. doi: 10.1128/mBio.01096-17.

3.

Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y.

Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11. Epub 2011 Sep 19.

4.

Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.

Murray JL, McDonald NJ, Sheng J, Shaw MW, Hodge TW, Rubin DH, O'Brien WA, Smee DF.

Antivir Chem Chemother. 2012 May 14;22(5):205-15. doi: 10.3851/IMP2080.

PMID:
22374988
5.

New assays and approaches for discovery and design of Sirtuin modulators.

Schutkowski M, Fischer F, Roessler C, Steegborn C.

Expert Opin Drug Discov. 2014 Feb;9(2):183-99. doi: 10.1517/17460441.2014.875526. Epub 2014 Jan 2. Review.

PMID:
24382304
6.

A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Hsu SF, Su WC, Jeng KS, Lai MM.

J Virol. 2015 Apr;89(7):3671-82. doi: 10.1128/JVI.03610-14. Epub 2015 Jan 14.

7.

Genome-wide RNAi screen for viral replication in mammalian cell culture.

Prusty BK, Karlas A, Meyer TF, Rudel T.

Methods Mol Biol. 2011;721:383-95. doi: 10.1007/978-1-61779-037-9_24.

PMID:
21431699
8.

Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.

Angelova M, Ortiz-Meoz RF, Walker S, Knipe DM.

J Virol. 2015 Aug;89(16):8474-83. doi: 10.1128/JVI.01002-15. Epub 2015 Jun 3.

9.

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.

Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O.

Antiviral Res. 2011 Sep;91(3):304-13. doi: 10.1016/j.antiviral.2011.07.006. Epub 2011 Jul 13.

PMID:
21777621
10.

The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.

Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M.

J Virol. 2014 May;88(10):5608-16. doi: 10.1128/JVI.03677-13. Epub 2014 Mar 5.

11.

Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza.

Wong JP, Christopher ME, Salazar AM, Sun LQ, Viswanathan S, Wang M, Saravolac EG, Cairns MJ.

Front Biosci (Schol Ed). 2010 Jan 1;2:791-800. Review.

PMID:
20036985
12.

Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity.

Paparisto E, Woods MW, Coleman MD, Moghadasi SA, Kochar DS, Tom SK, Kohio HP, Gibson RM, Rohringer TJ, Hunt NR, Di Gravio EJ, Zhang JY, Tian M, Gao Y, Arts EJ, Barr SD.

J Virol. 2018 Jun 13;92(13). pii: e00528-18. doi: 10.1128/JVI.00528-18. Print 2018 Jul 1.

13.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09. Epub 2010 Mar 29.

14.

Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication.

Sui HY, Zhao GY, Huang JD, Jin DY, Yuen KY, Zheng BJ.

PLoS One. 2009 May 22;4(5):e5671. doi: 10.1371/journal.pone.0005671.

15.

Resveratrol, sirtuins, and viruses.

Yang T, Li S, Zhang X, Pang X, Lin Q, Cao J.

Rev Med Virol. 2015 Nov;25(6):431-45. doi: 10.1002/rmv.1858. Epub 2015 Oct 19. Review.

PMID:
26479742
16.

A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cells.

Ehrhardt C, Dudek SE, Holzberg M, Urban S, Hrincius ER, Haasbach E, Seyer R, Lapuse J, Planz O, Ludwig S.

PLoS One. 2013 May 23;8(5):e63657. doi: 10.1371/journal.pone.0063657. Print 2013.

17.

Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes.

Edinger TO, Pohl MO, Yángüez E, Stertz S.

MBio. 2015 Jun 9;6(3):e00297. doi: 10.1128/mBio.00297-15.

18.

Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.

Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.

Peptides. 2011 Jul;32(7):1518-25. doi: 10.1016/j.peptides.2011.05.015. Epub 2011 May 19.

PMID:
21620914
19.

Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.

Baek YH, Song MS, Lee EY, Kim YI, Kim EH, Park SJ, Park KJ, Kwon HI, Pascua PN, Lim GJ, Kim S, Yoon SW, Kim MH, Webby RJ, Choi YK.

J Virol. 2015 Jan;89(1):287-99. doi: 10.1128/JVI.02485-14. Epub 2014 Oct 15.

20.

Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.

Osterlund P, Pirhonen J, Ikonen N, Rönkkö E, Strengell M, Mäkelä SM, Broman M, Hamming OJ, Hartmann R, Ziegler T, Julkunen I.

J Virol. 2010 Feb;84(3):1414-22. doi: 10.1128/JVI.01619-09. Epub 2009 Nov 25.

Supplemental Content

Support Center